149506-79-6

Basic information

• Product Name: 4-(dibenzylamino)cyclohexanone
• Synonyms: 4-(Dibenzylamino);4-(dibenzylamino)cyclohexanone;4-(dibenzylamino)cyclohexan-1-one
• CAS NO: 149506-79-6
• Molecular Formula: C₂₀H₂₃NO
• Molecular Weight: 293.40272
• Mol File: 149506-79-6.mol
• Article Data: 23

Chemical Properties

• Boiling Point: 427.1±40.0 °C(Predicted)
• Appearance: /
• Density: 1.10±0.1 g/cm3(Predicted)
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 7.20±0.20(Predicted)
• CAS DataBase Reference: 4-(dibenzylamino)cyclohexanone(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(dibenzylamino)cyclohexanone(149506-79-6)
• EPA Substance Registry System: 4-(dibenzylamino)cyclohexanone(149506-79-6)

Safety Data

• Hazard Codes: Xn
• Statements: 22
• Hazardous Substances Data: 149506-79-6(Hazardous Substances Data)

Usage

General Description

4-(dibenzylamino)cyclohexanone is a chemical compound with a molecular weight of 359.484 g/mol. It is also identified through its CAS number 2973-78-8. This chemical compound is structurally characterized by an amine group attached to a cyclohexanone ring, which is further substituted by benzyl groups. It belongs to the class of compounds known as Benzene and substituted derivatives. As of now, there isn't much information available regarding its usage, safety measures, and potential health effects. Its physical and chemical properties such as melting point, boiling point, solubility in different solvents, and stability under varying conditions also remain largely unknown.

Upstream product

• 59473-45-9 2-(chloromethyl)iodobenzene 
• 131511-13-2 4-(N-benzylamino)cyclohexanone ethylene acetal 
• 168893-04-7 N,N-dibenzyl-1,4-dioxaspiro[4.5]decan-8-amine 
• 4732-69-8 Chloro-oxo-acetic acid 
• 67-68-5 dimethyl sulfoxide 
• 149506-81-0 trans-4-(dibenzylamino)cyclohexanol 
• 79-37-8 oxalyl dichloride 
• 177906-47-7 trans-4-Hydroxycyclohexyldibenzylamine 
• 100-46-9 benzylamine 
• 4746-97-8 cyclohexanedione monoethylene ketal 
• 100-39-0 benzyl bromide 
• 6850-65-3 p-hydroxycyclohexylamine 
• 103-49-1 dibenzylamine 
• 50910-54-8 trans-4-aminocyclohexanol hydrochloride 

Downstream Products

• 883195-41-3 4-dibenzylamino-cyclohexanone oxime 
• 755039-85-1 trans-dibenzyl-[4-(4-phenyl-piperazin-1-yl)-cyclohexyl]-amine 
• 755039-86-2 cis-dibenzyl-[4-(4-phenyl-piperazin-1-yl)-cyclohexyl]-amine 
• 755039-80-6 trans-dibenzyl-(4-morpholin-4-yl-cyclohexyl)-amine 
• 755039-79-3 cis-dibenzyl-(4-morpholin-4-yl-cyclohexyl)-amine 
• 755039-81-7 trans-1-amino-4-dibenzylaminocyclohexane 
• 755039-89-5 (trans)-N,N-dibenzyl-4-[4-(cyclopropylmethyl)piperazin-1-yl]cyclohexanamine 
• 755039-88-4 (cis)-N,N-dibenzyl-4-[4-(cyclopropylmethyl)piperazin-1-yl]cyclohexanamine 
• 847798-79-2 4-(morpholin-4-yl)cyclohexan-1-amine 
• 31059-08-2 1-(1H-imidazol-1-yl)-2-methoxyethanone 

Relevant articles and documents

CYCLIN-DEPENDENT KINASE INHIBITING COMPOUNDS FOR THE TREATMENT OF MEDICAL DISORDERS

This invention is in the area of cell cycle inhibiting compounds for the treatment of disorders involving abnormal cellular proliferation, and include selective CDK2 inhibitors for medical therapy and their pharmaceutically acceptable salts and compositions.

TREATMENT OF CDK4/6 INHIBITOR RESISTANT NEOPLASTIC DISORDERS

This invention is to methods for treating disorders involving abnormal cellular proliferation that have developed resistance to a selective CDK4/6 inhibitor.

HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF ABNORMAL CELLULAR PROLIFERATION

This invention is in the area of heterocyclic-based compounds for the treatment of disorders involving abnormal cellular proliferation, including but not limited to tumors and cancers.